5% human albumin

DRUG3 trials

Sponsors

Emory University, William C. Oliver, Institute of Hematology & Blood Diseases Hospital, China

Conditions

FrailtyHemodynamic StabilityLung Injury, Acute (ALI)Plasma ExchangeRespiratory Distress Syndrome, Acute (ARDS)

Phase 2

Lactated Ringer's Versus 5% Human Albumin: Cardiac Surgical Patients

TerminatedNCT02654782

William C. OliverHemodynamic Stability

Start: 2016-01-31End: 2017-10-09Updated: 2019-04-16

Phase 3

Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI)

TerminatedNCT00796419

Emory UniversityLung Injury, Acute (ALI), Respiratory Distress Syndrome, Acute (ARDS)

Start: 2009-01-31End: 2016-11-30Updated: 2017-04-28

Unknown Phase

Human Albumin Combined With Plasma Exchange for Frailty Intervention

Not yet recruitingNCT07836127

Institute of Hematology & Blood Diseases Hospital, ChinaFrailty, Plasma Exchange

Start: 2026-09-24End: 2028-11-14Target: 34Updated: 2026-09-23